Hodgkin and Non-Hodgkin Lymphoma | Meet The Professor: The Current and Future Management of Hodgkin and Non-Hodgkin Lymphoma

Featuring perspectives from Dr Ian W Flinn, including the following topics:

• Hodgkin Lymphoma
  • Introduction (0:00)
  • Case: A man in his late 30s with well-controlled HIV and newly diagnosed Stage IV classic Hodgkin lymphoma receives brentuximab vedotin with doxorubicin/vinblastine/dacarbazine (AVD) — Neil Morganstein, MD (2:30)
  • Case: A man in his early 60s with classic Hodgkin lymphoma with a left lower lung mass and extensive regional lymphadenopathy receives brentuximab vedotin with AVD on the Phase III SWOG-S1826 trial — Ranju Gupta, MD (6:45)
• Mantle Cell Lymphoma (MCL)
  • Case: A man in his late 50s with newly diagnosed MCL blastoid variant — Zanetta S Lamar, MD (16:27)
  • Case: A man in his mid 50s with newly diagnosed Stage IV MCL — Shams Bufalino, MD (21:23)
• Follicular Lymphoma
  • Case: A man in his mid 60s with incidental diagnosis of Grade IIIA follicular lymphoma after admission to the hospital for a stroke — Bhavana (Tina) Bhatnagar, DO (36:28)
  • Case: A woman in her late 30s with extensive lymphadenopathy is diagnosed with Grade I/II follicular lymphoma and receives bendamustine/rituximab — Dr Morganstein (39:04)
• Diffuse Large B-Cell Lymphoma (DLBCL)
  • Case: A physically independent man in his early 80s with DLBCL and multiple comorbidities, including cardiac issues and peripheral neuropathy, experiences disease progression after R-GCVP — Syed F Zafar MD (49:53)
  • Case: A man in his mid 70s who presented with rapidly progressive proptosis of the left eye is diagnosed with DLBCL and receives R-CHOP and methotrexate CNS prophylaxis — Dr Lamar (55:21)

CME information and select publications